Using a surgical prostate-specific antigen threshold of >0.2 ng/mL to define biochemical failure for intermediate- and high-risk prostate cancer patients treated with definitive radiation therapy in the ASCENDE-RT randomized control trial
- 20 September 2018
- journal article
- research article
- Published by Elsevier BV in Brachytherapy
- Vol. 17 (6), 837-844
- https://doi.org/10.1016/j.brachy.2018.08.008
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate CancerInternational Journal of Radiation Oncology*Biology*Physics, 2017
- Late Urinary Side Effects 10 Years After Low-Dose-Rate Prostate Brachytherapy: Population-Based Results From a Multiphysician Practice Treating With a Standardized Protocol and Uniform Dosimetric GoalsInternational Journal of Radiation Oncology*Biology*Physics, 2014
- Adjuvant and Salvage Radiotherapy After Prostatectomy: AUA/ASTRO GuidelineJournal of Urology, 2013
- Population‐based 10‐year oncologic outcomes after low‐dose‐rate brachytherapy for low‐risk and intermediate‐risk prostate cancerCancer, 2012
- Rectal toxicity and rectal dosimetry in low-dose-rate 125I permanent prostate implants: A long-term study in 1006 patientsBrachytherapy, 2012
- Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancerRadiotherapy and Oncology, 2012
- Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupBJU International, 2012
- Permanent prostate brachytherapy preplanned technique: The modern Seattle method step-by-step and dosimetric outcomesBrachytherapy, 2009
- Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective studyWorld Journal of Urology, 2009
- Randomized Trial Comparing Iridium Implant Plus External-Beam Radiation Therapy With External-Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the ProstateJournal of Clinical Oncology, 2005